tiprankstipranks

My Biotech Portfolio - New Portfolio

PerformancePortfolio Details

Grant Jiao

My Biotech Portfolio
Individual Investor
Ranked #680,942 out of 859,217 TipRanks' Investors
Success Rate
37%
77 out of 209
profitable transactions
Average Return
-16.06%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 19.42%
6-Month Return▲ 7.82%
12-Month Return▲ 72.99%
YTD Return▲ 19.78%
Total Return▲ 18.99%

Best Trade

AssetMirum Pharm... (MIRM)
Opened at
Closed at-
Gain▲ 454.98%

Bio

Focus on breakthrough biotech companies with long term appreciation opportunities

Performance

25.31%0-25.31%
▲ 12.88%
▲ 3.56%
▲ 4.86%
Sep 2025
▲ 10.96%
▲ 2.38%
▼ 4.20%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 2.71%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 5.72%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 4.15%
Jan 2026
▼ 1.12%
▼ 0.86%
▲ 2.06%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 10.07%
Mar 2026
▲ 10.48%
▲ 6.78%
▲ 25.31%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%▲ 4.86%
▲ 10.96%▲ 2.38%▼ 4.20%
▼ 3.68%▲ 0.19%▼ 2.71%
▼ 0.10%▲ 0.08%▼ 5.72%
▲ 4.06%▲ 1.47%▲ 4.15%
▼ 1.12%▼ 0.86%▲ 2.06%
▲ 0.60%▼ 4.94%▼ 10.07%
▲ 10.48%▲ 6.78%▲ 25.31%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
KANT
Kineta
―
▼ 99.04%
8
Close
Jun 30, 2025
HURA
TuHURA Biosciences
0.02%
▲ 41.26%
1
Open
Jun 30, 2025
ITCI
Intra-Cellular Therapies
―
▲ 362.48%
8
Close
Apr 01, 2025
MRNS
Marinus
―
▼ 96.03%
5
Close
Feb 10, 2025
ONCT
Oncternal Therapeutics
―
▼ 99.53%
5
Close
Dec 02, 2024
TCON
TRACON Pharmaceuticals
―
▼ 37.40%
5
Close
Dec 02, 2024
GMDAQ
Gamida Cell
―
▼ 99.83%
4
Close
May 24, 2024
SIOX
Sio Gene Therapies
―
▼ 54.15%
5
Close
Feb 07, 2024
ZYNE
Zynerba Pharmaceuticals
―
▼ 65.80%
5
Close
Oct 10, 2023
CHRS
Coherus Biosciences
0.57%
▼ 45.80%
4
Buy
Sep 11, 2023
SURF
Surface Oncology
―
▼ 87.14%
7
Close
Sep 11, 2023
AGTC
Applied Genetic Technologies
―
▼ 92.22%
9
Close
Nov 30, 2022
CRVS
Corvus Pharmaceuticals
0%
▲ 147.16%
1
Open
Sep 18, 2021
PLTR
Palantir Technologies
0%
▲ 430.49%
1
Open
Sep 08, 2021
ATOS
Atossa Therapeutics
0%
▼ 91.24%
1
Open
Jun 10, 2021
ARDX
Ardelyx
0.16%
▼ 9.18%
2
Sell
Mar 20, 2021
MIRM
Mirum Pharmaceuticals
24.84%
▲ 417.39%
7
Sell
Mar 20, 2021
ZVRA
Zevra Therapeutics
2.51%
▲ 22.78%
7
Sell
Mar 20, 2021
CRIS
Curis
0.03%
▼ 97.80%
6
Sell
Mar 20, 2021
CARM
Carisma Therapeutics
0.01%
▼ 99.85%
6
Sell
Mar 20, 2021